Posts Tagged: Watson Pharmaceuticals


FTC charges Endo Pharmaceuticals with antitrust violations for pay for delay patent settlements

The FTC’s complaint alleges that Endo paid the first generic companies that filed for FDA approval – Impax Laboratories, Inc. and Watson Laboratories, Inc. – to eliminate the …
By Gene Quinn
3 years ago 6

Companies Agree to Sell Rights to 18 Drugs to Satisfy FTC

The Federal Trade Commission will require Watson Pharmaceuticals, Inc. and Actavis Inc. to sell the rights and assets to 18 drugs to Sandoz International GmbH and Par Pharmaceuticals, …

FTC Seeks SCOTUS Review in AndroGel “Pay-for-Delay” Case

At the request of the Federal Trade Commission, the Solicitor General of the United States petitioned the U.S. Supreme Court to review a recent federal appeals …
By Gene Quinn
7 years ago 4